International Biotechnology Trust PLC Aurinia Pharmaceuticals Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 1,040,530 shares of AUPH stock, worth $9.22 Million. This represents 2.74% of its overall portfolio holdings.

Number of Shares

1,040,530

Previous 573,530 81.43%

Holding current value

$9.22 Million

Previous $5.55 Million 45.63%

% of portfolio

2.74%

Previous 1.73%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $3.63 Million - $5.73 Million	467,000 Added 81.43%	1,040,530 $8.08 Million
Q3 2022 Nov 08, 2022	BUY	$6.66 - $12.39 $3.78 Million - $7.03 Million	567,772 Added 9860.58%	573,530 $4.31 Million
Q2 2022 Aug 16, 2022	SELL	$8.95 - $12.8 $3.84 Million - $5.49 Million	-429,242 Reduced 98.68%	5,758 $574 Million
Q1 2022 May 20, 2022	BUY	$10.05 - $22.48 $1.01 Million - $2.26 Million	100,500 Added 30.04%	435,000 $5.39 Million
Q4 2021 Feb 15, 2022	BUY	$17.78 - $33.08 $3.75 Million - $6.98 Million	211,000 Added 170.85%	334,500 $7.65 Million
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $1.91 Million - $4.12 Million	-175,000 Reduced 58.63%	123,500 $2.72 Million
Q1 2021 May 17, 2021	BUY	$12.3 - $18.73 $2.71 Million - $4.12 Million	220,000 Added 280.25%	298,500 $3.88 Million
Q4 2020 Feb 19, 2021	SELL	$12.94 - $16.05 $472,310 - $585,825	-36,500 Reduced 31.74%	78,500 $1.09 Million
Q3 2020 Dec 01, 2020	BUY	$13.19 - $16.66 $1.52 Million - $1.92 Million	115,000 New	115,000 $1.69 Million

Others Institutions Holding AUPH

# of Institutions

208

Shares Held

58.6M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.26B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Aurinia Pharmaceuticals Inc. Transaction History